Understanding the risks of alcohol use in people with HIV and those aging
Personalizing Risk from Alcohol among HIV+/-: Genetics, Medication Toxicity and PEth
['FUNDING_P01'] · YALE UNIVERSITY · NIH-10906195
This study is looking at how drinking alcohol might affect the health of people living with HIV, especially as they get older and take different medications, so if you're in this situation, your input could help us understand the risks better.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-10906195 on ClinicalTrials.gov |
What this research studies
This research investigates the health risks associated with alcohol consumption among individuals living with HIV, particularly as they age and take multiple medications. It focuses on how alcohol interacts with commonly prescribed antiretroviral drugs and other medications, which can lead to serious health complications. By assessing factors like genetic predisposition, alcohol use patterns, and the number of medications taken, the study aims to identify specific risks for conditions such as liver disease and cognitive decline. Participants will provide information about their alcohol use and medication regimens to help researchers better understand these complex interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living with HIV who are also taking multiple medications and consume alcohol.
Not a fit: Patients who do not have HIV or are not taking multiple medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to personalized treatment strategies that minimize health risks for individuals with HIV who consume alcohol.
How similar studies have performed: Previous research has shown that understanding the interactions between alcohol and medications can significantly improve patient outcomes, indicating that this approach has potential for success.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JUSTICE, AMY CAROLINE — YALE UNIVERSITY
- Study coordinator: JUSTICE, AMY CAROLINE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Alcoholic Liver Diseases